PDS Biotechnology Corp Files 8-K on Officer/Director Changes
Ticker: PDSB · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, governance, filing
TL;DR
PDS Biotech leadership shuffle, board changes, and compensation updates filed.
AI Summary
PDS Biotechnology Corporation filed an 8-K on June 11, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in key personnel and board composition can signal internal shifts or strategic realignments that may carry inherent risks.
Key Numbers
- 20250611 — Report Date (Date of the 8-K filing)
- 001-37568 — SEC File Number (Registrant's SEC file number)
Key Players & Entities
- PDS Biotechnology Corp (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 26-4231384 (identifier) — IRS Employer Identification No.
- 303A College Road East Princeton, NJ 08540 (address) — Principal Executive Offices
- Edge Therapeutics, Inc. (company) — Former company name
FAQ
Who specifically departed from their roles at PDS Biotechnology Corp?
The filing indicates the departure of directors or certain officers, but specific names are not detailed in the provided text.
Were there any new directors or officers appointed?
Yes, the filing explicitly mentions the election of directors and the appointment of certain officers.
What specific matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not specified in the provided text.
What is the primary business of PDS Biotechnology Corp?
PDS Biotechnology Corp is in the Pharmaceutical Preparations industry, SIC code 2834.
When is PDS Biotechnology Corp's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding PDS Biotechnology Corp (PDSB).